Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3727_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
29 Мб
Скачать
144 Chapter 15 Intravascular ultrasound
https://t.me/med1917
15.4 Three ways to determine vein diameter and measurement variation.
(Images courtesy of Dr. Paul Chouinard.)
15.5 Various presentations of post-thrombotic scars in veins.
evident on the initial venogram. However, a scar develops after DVT resolution within the vein wall (i.e., intramu­ral) and in the lumen (i.e., intraluminal) that affects the expansion, lumen size, and compliance of the vein. This is often not evident with a venogram. The conguration and distribution of a post-thrombotic scar can be variable (Fig­ure15.5). Unlike with nonthrombotic lesions, the stenosed
post-thrombotic vein is treated with balloon dilation to the appropriate (i.e., idealized) size and stented to the same size in a 1:1 ratio. Areference vessel is less import­ant in calculating the severity of the stenosis or diameter of the vein in these patients suffering from clinical CEAP 4–6 CVH. The veins are generally diffusely narrowed and the stents well-anchored over a long distance. What is
15.4 IVUS-identified venous anatomy affects stent placement strategy 145
https://t.me/med1917
critical, however, is that all scarred segments of the vein are treated so that no inow or outow lesions to the stent are left unaddressed (Figure15.5). The extent of damaged vein with scarring is much more accurately detected with IVUS than with venogram. an angioplasty and stents will affect stent patency and clinical success. What is also paramount in these patients is to use IVUS to conrm both adequate stent expansion and vein lumen gain (9), which predicts adequate ow to prevent stent thrombosis from relative stasis. Conrming diffuse vein wall apposition (Figure15.6) is also important to ensure stent xation and decrease concerns about stent migration.
Treating all scarred veins with
15.4 IVUS-IDENTIFIED VENOUS ANATOMY AFFECTS STENT PLACEMENT STRATEGY
Helpful information gained from IVUS includes pelvic vein anatomy (Figure15.7). Identifying the junction of the common iliac vein and inferior vena cava (IVC) and where the point of compression might be relative to that conu­ence can be helpful for successful stenting. It is clear with IVUS that the inferior portion of the IVC is sometimes the point of compression rather than the common iliac vein and that when the common iliac vein is compressed on the left or right, it is not always adjacent to the junction with the IVC, but rather is sometimes 2–3 centimeters caudal to that point. Additionally, identifying the junction
of the internal (IIV) and external iliac (EIV) veins to form the common iliac vein can be helpful in determining stent length. In some patients the distance from IVC to this con­uence of the IIV and EIV can be short, while in other patients longer. An additional benet of identifying the junction of the external and internal iliac vein is to allow identication of the mid-portion of the external iliac vein which dips into the pelvis. Positioning the cranial or caudal end of a stent in the mid-portion of the external iliac vein which is positioned in the deepest part of the pelvis often leads to distortion of the nonstented adjacent vein segment, which may have long-term hemodynamic effects. Also, as the stent straightens over time, it can erode through the side of the vein in these curved sections of the vein. There­fore, it is better to plan the end of a stent to be in the upper or lower third of the external iliac vein to avoid potential future complications. In all patients with stents extending into the common femoral vein, and especially those who have diffuse post-thrombotic scarring, IVUS is particularly helpful in identifying the inow vessels to the common femoral vein, namely the femoral vein and deep femoral vein. In these patients, the femoral vein is often diffusely diseased from prior DVT and scarring To have adequate inow to a common femoral vein stent, it is important to end the common femoral vein stent cranial to the junction with the deep femoral vein (Figure15.8). In post-throm­botic patients, it is eased and widely patent inferior common femoral vein or to the junction of the common femoral vein with the widely patent deep femoral vein to ensure adequate inow to the stent and avoid stent thrombosis and gain long-term stent
important to stent to either a non-dis-
15
15.6 Stent and vein wall apposition
146 Chapter 15 Intravascular ultrasound
https://t.me/med1917
15.7 Pelvic vein anatomy easily identied with IVUS. (for abbreviations, see text).
15.8 Venogram and IVUS detected post-thrombotic occlusive or near-occlusive scars In the CFV, DFV and FV.
patency. There are often two deep femoral veins identied with IVUS, and conrming the location and the absence of scarring at the junction with the common femoral vein pro­vides important information about where to land the stent.
In the setting where IVUS and venogram determine that the common femoral, femoral, and deep femoral veins are all diffusely stenosed due to a post-thrombotic scar, CFV stenting should be avoided to prevent stent thrombosis due to poor inow, which may actually worsen the patient’s clinical condition.
15.5 CONCLUSION
The more experience we gain with IVUS for the diagnosis and treatment of deep venous occlusive disease, the more critical to success it becomes and the more questions about
optimal use arise. It is not enough to pull the IVUS catheter through the length of vein segments of interest to identify stenosis and calculate its severity. Relying on dynamic IVUS imaging to expand your real-time understanding of venous anatomy and pathology is important to avoid false-positive lesions and undersizing stents. Identifying the pelvic venous anatomy, especially the deep femoral vein, as an adequate inow vessel in those patients with diffuse post-thrombotic disease may prevent stent thrombosis. This technical detail whereby adequate stent inow is assured is just as import­ant for procedural success as post-stenting anticoagulation. IVUS conrmation of stent expansion and wall apposition and adequate and disease-free venous inow and outow are the details of each stent case necessary to improve suc­cess.
Further research on what is an IVUS-determined crit-
ical lesion and whether it is the same for all degrees (i.e.,
References 147
https://t.me/med1917
clinical classes CEAP 4–6) of advanced symptomatic CVH needs to be performed. Additional studies on how to best use IVUS to calculate vein diameters to assure proper stent selection is also necessary.
Excellent research has been done to date and has bene­ted a large group of patients. More investigation is needed to rene both our imaging and image interpretation to better guide treatment and reliably obtain optimal patient outcomes.
Consensus Statements 15.0 of the American Venous Forum on the use of intravascular ultrasound
No. Consensus Statements
15.1 A >50% cross-sectional area reduction measured by IVUS in symptomatic patients results in measurable clinical improve-
ment following iliac vein stent placement.
15.2 IVUS is helpful to select the appropriate size of venous stents.
15.3 IVUS-identied pelvic venous anatomy aids in the placement of iliac vein stents.
REFERENCES
Systematic review
1. Raju S, Neglen P. High prevalence of nonthrombotic iliac vein lesions in chronic venous disease: Apermissive role in pathogenicity. J Vasc Surg. 2006 Jul;44(1):136–144
2. Neglén P, Hollis KC, Olivier J, Raju S. Stenting of the venous outow in chronic venous disease: Long-term stent-related outcome, clinical, and hemodynamic result. J Vasc Surg. 2007 Nov;46(5): 979–990
3. Neglen P, Raju S. Intravascular ultrasound scan evaluation of the obstructed vein. J Vasc Surg. 2002 Apr;35(4):694–700
4. Gagne PJ, etal. Venography versus intravascular ultrasound for diagnosing
and treating iliofemoral vein obstruction. J Vasc Surg Venous Lymphat Disord. 2017 Sep;5(5):678–687
5. Murphy E, etal. Pivotal study evaluating the safety and effectiveness of the Abre venous self-expanding stent system in patients with symptomatic iliofemoral venous outow obstruction. Circulat Cardiovasc Intervent. 2022 Feb;15(2):2
6. Black S, etal. ABRE study: Clinical outcomes through 36 months. Presented at the American Vein and Lymphatic Society, New Orleans, LA, October, 2022
7. Sayed MH, Salem M, Desai KR, O’Sulli-
van GJ, Black SA. Incidence, outcome and management of venous stent migration:
Asystematic review. J Vasc Surg Venous Lymphat Disord. 2022;10:482–490
8. Rossi FH, etal. Randomized double­blinded study comparing medical treatment versus iliac vein stenting in chronic venous disease. J Vasc Surg Venous Lymphat Disord. 2018 Mar; 6(2):183–191
9. Gagne PJ, etal. Analysis of threshold stenosis by multiplanar venogram and intravascular ultrasound examination for predicting clinical improvement after ilio­femoral vein stenting in the VIDIO trial. J Vasc Surg Venous Lymphat Disord. 2018 Jan;6(1):48–56
10. Chouinard P, etal. Sources of error in measuring vein size. Presentation at AVLS, Denver, CO, October2021
15
https://t.me/med1917
CHAPTER
16
https://t.me/med1917
Computed tomography and magnetic
resonance imaging in venous disease
Thanila A. Macedo, Terri J. Vrtiska, and James F. Glockner
16.1 INTRODUCTION
Current diagnostic evaluation of disorders of the venous system has beneted from advances in state-of-the-art com­puted tomography (CT) and magnetic resonance imaging (MRI) applications. An understanding of the fundamentals and the appropriate utilization of each technology will provide useful information for medical management and decisions regarding surgical or endovascular interventions for venous disease.
16.2 IMAGING TECHNOLOGIES: CT OF VENOUS DISEASE
During the past decade, CT has become a standard nonin­vasive imaging modality for the depiction of a wide variety of vascular anatomies and pathologies. Modern CT acqui­sitions have evolved from single-detector spiral scanners to multichannel helical CT examinations. More recently, 256­slice, 320-slice, and dual-energy CT systems have become available in many practices and have replaced catheter-di­rected vascular imaging for many diagnostic studies. The proper application of modern CT techniques provides an extremely accurate, time-efcient, and cost-effective diag­nostic evaluation prior to surgical or endovascular inter­vention.
The two dominant advantages of CT are the speed and resolution of image acquisition. Modern CT acquisitions can be acquired in less than a minute during a single breath­hold, minimizing motion artifact. In addition, submillime­ter resolution details are available for accurate depiction of the imaging ndings, which can be communicated to cli­nicians using advanced postprocessing techniques and 3D displays (Figure16.1). One additional distinct advantage of CT compared with MRI is the ability to demonstrate calcied densities such as calcied granulomatous lymph nodes as a cause of superior vena cava (SVC) obstruction on precontrast acquisitions.
The two primary disadvantages of CT imaging of the venous system include radiation exposure and the necessity for administration of iodinated contrast material. Atypical abdominal and pelvic CT evaluation includes a radiation
exposure of approximately 5–10 mSv. Ongoing efforts within the CT physics community are focused on optimiz­ing the necessary radiation required for CT acquisitions by tailoring the dose to the individual patient size via modu­lation of the radiation beam. contrast material is necessary for accurate evaluation of the venous system, and therefore, patients with a signicant allergic reaction to iodinated contrast material or signi­cant decrease in renal function should be evaluated with alternative imaging techniques, including ultrasound or MRI.
1
Administration of iodinated
16.2.1 Clinical applications
16.2.1.1 SVC and brachiocephalic veins
CT evaluation of the SVC is most commonly performed for the evaluation of acute or chronic occlusive changes and has been shown to be a useful noninvasive imaging technique for the diagnosis of SVC and central venous dis-
2–5
orders. ing endovascular stent patency or postoperative changes of surgically placed bypass grafts, can also be performed. Regardless of the indication, CT acquisitions are optimally performed by the simultaneous injection of the antecubi­tal veins using 90–100 mL of dilute (1:3 contrast-to-saline ratio) contrast material in each extremity at an injection rate of 2–3 mL/second (direct CT venogram). The bilat­eral arm injections provide homogeneous opacication of the innominate veins and SVC and avoid potential artifacts from unopacied blood within the central venous struc­tures (Figure16.2). Subsequent injection of 20–30cm saline is helpful for ushing the contrast material from the brachial and axillary veins into the central venous system. Alternatively, indirect CT venogram can be obtained with injection of full concentration contrast through a periph­eral or central intravenous access and delayed image acqui­sition. CT acquisition using thin collimation (1–2mm) is useful in order to provide both traditional axial images and appropriate reconstructions that can be analyzed in the coronal, sagittal, or tailored off-axis planes. Careful review of the axial images and dedicated reconstructions are use­ful for optimal visualization of venous patency, obstructed venous segments, intraluminal thrombus, and collateral venous pathways.
Evaluation of postprocedural changes, includ-
3
of
DOI: 10.1201/9781003328971-18
149149
150 Chapter 16 Computed tomography and MRI in venous disease
(a)
(b)
https://t.me/med1917
16.1 Current computed tomography technology combined with tailored acquisition techniques and postprocessing applications
provide accurate depiction of (a) the thoracic and (b) abdominal venous vasculature.
16.2 (a, b) Contrast-enhanced axial and (c) coronal computed tomography of the chest demonstrate artifactual low-density lling
defects because of unopacied blood ow from the right jugular vein and unopacied blood from the left brachiocephalic vein enter­ing the opacied right brachiocephalic vein (a and c, arrows) and the superior vena cava (b and c, arrowheads).
16.2 Imaging technologies: CT of venous disease 151
https://t.me/med1917
16
16.3 Acute thrombotic occlusion. (a) Coronal CT image acquired with iodinated contrast material injected simultaneously via bilat-
eral antecubital IV access shows low-attenuation thrombus in distended right and left brachiocephalic veins (arrows) consistent with acute deep vein thrombosis. (b) Subsequent postlysis catheter venogram with widely patent brachiocephalic veins.
16.4 Chronic occlusive changes. 3D reconstruction of indirect CT venogram with volume-rendered image. (a) There is nonopacica-
tion of the right (arrow) and left (arrowhead) brachiocephalic veins with associated chest wall and lower neck collaterals. (b) Another patient with absent right subclavian and brachiocephalic veins (white arrow) with chest wall collaterals and prominent azygous vein (black arrow). The right axillary remains patent (arrowhead). Note the presence of a left subclavian central venous catheter.
On contrast-enhanced (CE) CT images, acute thrombus within the SVC or central venous structures is characterized by a low-attenuation lling defect within the lumen of the vessel (Figure16.3). The involved venous segment may be normal caliber or expanded. Chronic occlusive changes are most commonly visualized as small, nonopacied, brot­ic-appearing linear densities or an absent venous segment. Extensive upper chest wall and azygous collaterals can be precisely depicted by 3D images (Figure16.4).
An advantage of evaluation of the SVC and central venous structures by CT rather than catheter venography is the ability of CT to accurately depict the underlying pathol­ogy causing venous occlusive cause of obstruction of the SVC and upper venous struc­tures is malignancy, most commonly pulmonary neoplasm. The obstruction may result from extrinsic compression due to primary or metastatic neoplasm or from direct invasive changes. Iatrogenic occlusive changes are increasingly seen
changes. The most common
152 Chapter 16 Computed tomography and MRI in venous disease
https://t.me/med1917
16.5 (a) Volume-rendered 3D reconstruction of indirect CT venogram in a patient with SVC syndrome performed for surgical plan-
ning. No peripheral IV access could be obtained, and contrast was injected through a femoral central line. botic changes are demonstrated with a small left internal jugular in the upper neck (arrowhead) and absent in the lower neck. Bilateral subclavian, brachiocephalic, and SVC stents are occluded with multiple lower neck and chest wall collaterals as well as a prominent azygous vein (curved arrow). Preserved venous inow through a patent right internal jugular vein (arrows) is shown. Repeat postop­erative CT venogram with volume-rendered vein–to–right atrium bypass graft without signicant stenosis. Note the detailed anatomy displayed by the volume-rendered image showing the antibiotic beads (arrows) adjacent to the prosthetic graft in this immunosuppressed patient.
(b) and curved planar reformat (c) 3D reconstruction shows a patent right internal jugular
(a) Chronic-post throm-
16.6 Contrast-enhanced axial (a) and coronal (b) computed tomography demonstrates ow artifact (arrow) from unopacied blood
from the infrarenal inferior vena cava streaming into the juxtarenal (IVC) with admixture of opacied blood from the renal veins (arrowhead).
as the reason for obstruction due to widespread use of central venous catheters and transvenous cardiac devices. Postradiation changes may also result in iatrogenic SVC obstruction. Another common cause of SVC obstruction includes granulomatous disease. Anatomic variants of the SVC can also be accurately visualized by CT evaluation, such as a left-sided SVC.
CT is used preoperatively to delineate the extent of disease (Figure16.5) and help with surgical or endovas­cular treatment planning. Demonstration of the inow, obstructed segment, and outow is important information required prior to intervention. This is especially import­ant when protocoling the exam and deciding on the area of body coverage to be included in the study. CT is the preferred modality and is widely used postoperatively to
evaluate central venous bypass or endovascular stents where ultrasound has a limited role (Figure16.5). Ultra­sound cannot directly visualize the SVC or brachiocephalic veins due to the deep anatomic location in the chest and lack of appropriate scanning window.
16.2.1.2 Inferior vena cava and iliac veins
Accurate evaluation of the inferior vena cava (IVC) requires knowledge of potential ow artifacts that are especially prominent due to the rapid acquisition provided by mod­ern CT scanning (Figure16.6). In addition, knowledge of anatomic variation of the IVC is important for determining the accurate evaluation of ndings due to anatomic varia­tion rather than pathology (Figures16.7 and 16.8).
6–9
The
16.2 Imaging technologies: CT of venous disease 153
https://t.me/med1917
16.7 Contrast-enhanced axial computed tomography (a) and volume-rendered 3D reconstruction (b) demonstrate the anatomic
relationships of a retroaortic left renal vein (arrows).
16
16.8 Contrast-enhanced axial (a) and coronal (b) computed tomography demonstrates duplication of the infrarenal inferior vena
cava (IVC) with a right-sided (arrow) and left-sided infrarenal IVC (arrowhead).
ow artifact visualized within the IVC is due to the unopac­ied blood from the lower extremities entering the infrare­nal IVC, whereas the suprarenal IVC receives an admixture of opacied blood due to the rapid transit of the contrast material through the kidneys. Anatomic variants of the IVC are due to persistent embryologic remnants. The prevalence of the most common anatomic variants includes persistence of a solitary left-sided IVC (<1%) and duplication of the infrarenal IVC segment (1%–3%), retroaortic left renal vein (2%–3%), and circumaortic left renal vein (2%–9%).
Optimal opacication of the IVC typically requires delayed CT imaging at 90–120 seconds following the administration of an appropriate volume of iodinated con­trast material to allow homogeneous opacication of the entire infrarenal cava. Typically, between 150 and 200 mL of iodinated contrast is required for optimal venous opaci­cation. As with the SVC, current CT evaluation provides accurate off-axis display of the entire caval segment in any orientation; however, the coronal display most commonly provides the best depiction because of the craniocaudal orientation of the IVC within the abdominal cavity. The iliac veins require multiplanar evaluation due to tortuosity and are often better displayed with curved planar reformat 3D reconstruction where the vein can be elongated and entirely displayed in one image. The most common pathol­ogy depicted within the IVC is bland thrombus either due
7
to thrombotic disease and may be visualized within the central cava and iliac veins (Figure16.9) or due to exten­sion of thrombus from malignant occlusive changes (Fig­ure16.10). Thrombus may also be visualized within venous branches, such as the renal veins or common femoral veins (Figure16.11). Tumor thrombus within the IVC is most commonly due to local extension from adjacent organs such as the kidneys (renal cell carcinoma), liver (hepatocel­lular carcinoma), or adrenal glands (adrenal cortical carci­noma). An uncommon cause of a lling defect within the IVC is due to a primary tumor arising in the smooth muscle of the IVC, as seen with leiomyosarcoma. IVC may be traumatically disrupted (Figure 16.12). The ability of the CT evaluation to display the orientation of an IVC lter can be helpful for depicting migration (Figure
16.13a)
or thrombus (Figure16.13b).
10,11
Rarely, the
16.2.1.3 Pulmonary arteries
CT of the pulmonary arteries has largely replaced cathe­ter-directed pulmonary angiography and ventilation and perfusion scintigraphy (VQ scans) because of the wide availability, rapidity of the scan’s acquisition, and the high sensitivity and specicity (approaching 100%) for central pulmonary emboli. small subsegmental pulmonary emboli has been shown to be less accurate, with a sensitivity of 83% and a specicity
12,13
In other studies, the detection of